Edward G. Broenniman
Chairman of the Board
Edward G. Broenniman is an entrepreneur with substantial experience in the formation and development of high technology businesses. He became a director of Aethlon Medical, Inc. in March of 1999. Mr. Broenniman has 30 years of management and executive experience with high-tech, privately held growth firms where has he served as CEO, COO, or corporate advisor. He recently served on the Board of Directors of publicly traded QuesTech (acquired by CACI International), and currently is a director of four privately-held companies. His non-profit Boards are the Dingman Center for Entrepreneurship's Board of Advisors at the University of Maryland, the National Association of Corporate Directors, the National Capital Chapter, and the Board of the Association for Corporate Growth. Mr. Broenniman holds a BA from Yale University and an MBA from Stanford University.
Angela Rossetti
Director and Chair of Nominating and Corporate Governance Committee
Dr. Rossetti has previously held board seats with companies in women’s health and rare disease, and with Danske Bank advising on their biotech funds.
Previously, she was a Global Vice President in commercial development at Pfizer and held positions of increasing responsibility in marketing at Wyeth. She has served as a strategic consultant to Kala Pharmaceuticals and Celgene Corporation before its acquisition by Bristol Myers Squibb, and was Executive Vice President at Cell Machines, Inc., an early-stage biopharmaceutical company developing novel protein therapies for hemophilia.
Dr. Rossetti holds a Doctorate in Bioethics from Loyola University Chicago where she focused on Research Ethics and Rare Disease ethics. She also holds an MBE from Montefiore Einstein, an MBA from Columbia University, and a BA in Biology and English from the University of Pennsylvania. She is a member of the Empire State Bioethics Consortium and a charter member of the Biopharmaceutical Industry Bioethics Forum, founded by Eli Lily in 2016.
Chetan S. Shah, M.D.
Director and Chair of Compensation Committee
Dr. Shah became a director of Aethlon Medical in June 2013. Dr. Shah is a board certified Otolaryngologist. He is an Advisory Board Member at The Bank of Princeton, and a founder, partner and Board member of the Surgery Center at Hamilton as well as Physician Management Systems and Princeton Eye & Ear.
Dr. Shah serves on the board of two other private companies. He holds teaching positions and serves on multiple hospital committees in the area and served as Vice-President on the Board of Medical Examiners for the State of New Jersey. Dr. Shah received his Bachelor’s degree and Medical Degree from Rutgers University and Robert Wood Johnson Medical School.
Nicolas Gikakis
Director
From 2021 to May 2023, Mr. Gikakis served as the Head of Commercial for WearOptimo Pty Ltd, a private Australian medical device and digital health company. Previously, from 2017 to 2019, Mr. Gikakis was Vice President of Strategy and Corporate Development at Oventus Medical Limited, a private medical device company, during which time he assisted with the commercial expansion of its sleep apnea device. From 2012 to 2021, Mr. Gikakis held various leadership and independent strategic advisor positions in the healthcare industry in sales, marketing, product development, and corporate development and transactions, including for companies working with blood filtration and purification.
Mr. Gikakis earned a BS in bioengineering from the University of Pennsylvania and holds an MBA from George Mason University, with earlier work in bench and clinical research, and clinical experience at the University of Pennsylvania.
James B. Frakes
Chief Executive Officer and Chief Financial Officer
Mr. Frakes joined Aethlon Medical in January 2008. He has 27 years of CFO level financial responsibility for publicly traded companies, as well as, specific knowledge and experience in equity (IPO, follow-on public offerings and private placements) and debt transactions, acquisitions, public reporting and Sarbanes-Oxley section 404 internal control requirements.
Mr. Frakes received an MBA from the University of Southern California, and completed his BA with Honors at Stanford University.